ASTRAZENECA PLC (AZN)
Clinical trial NCT06978660 updates: 1. completion date: 2026-05-01 → 2026-12-31 2. primary completion date: 2026-05-01 → 2026-09-30 3. enrollment: 2000 → 2200 participants
Clinical trial NCT06978660 updates: 1. completion date: 2026-05-01 → 2026-12-31 2. primary completion date: 2026-05-01 → 2026-09-30 3. enrollment: 2000 → 2200 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical